Antimicrobial peptides: primeval molecules or future drugs?
Graduate Program in Life Sciences, Microbiology and Immunology Program, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America.
Brian M
BM
Peters
Mark E
ME
Shirtliff
Mary Ann
MA
Jabra-Rizk
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D023181:Antimicrobial Cationic Peptides / Q000737:chemistry / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial / Q000235:genetics; D006801:Humans; D057131:Immune Evasion / Q000235:genetics / Q000502:physiology; D007113:Immunity, Innate / Q000235:genetics / Q000502:physiology; D008954:Models, Biological; D008958:Models, Molecular; D013329:Structure-Activity Relationship; D023084:alpha-Defensins / Q000737:chemistry / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D023084:alpha-Defensins